139 related articles for article (PubMed ID: 38695571)
21. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (3rd report): Cost impact of transurethral resection of bladder tumor in Japan.
Fukuhara H; Hagiwara Y; Oba K; Inoue K
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103758. PubMed ID: 37604217
[TBL] [Abstract][Full Text] [Related]
22. Significance of 5-Aminolevulinic Acid-mediated Photodynamic Diagnosis Following Standard Transurethral Resection in Non-muscle Invasive Bladder Cancer.
Watanabe K; Tamura K; Matsushita Y; Watanabe H; Motoyama D; Ito T; Sugiyama T; Otsuka A; Miyake H
Cancer Diagn Progn; 2021; 1(3):201-205. PubMed ID: 35399308
[TBL] [Abstract][Full Text] [Related]
23. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results.
Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J;
Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Risk Factors for Recurrence after Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder Cancer: 2-Year Follow-Up Outcomes.
Li H; Wang L; Li H; Zhang P; Li Z; Xue L; Wang Z; Fu D; Chen Q; Luo Q; Chong T; Wang Z
Oncology; 2024; 102(4):337-342. PubMed ID: 37647883
[TBL] [Abstract][Full Text] [Related]
25. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
[TBL] [Abstract][Full Text] [Related]
26. Reduced Recurrence Rates Are Associated with Photodynamic Diagnostics Compared to White Light after Extended Transurethral Resection of Bladder Tumors.
Marquardt A; Richterstetter M; Taubert H; Hartmann A; Wullich B; Lieb V; Bellut L; Wach S; Apel H
Life (Basel); 2022 Apr; 12(5):. PubMed ID: 35629309
[TBL] [Abstract][Full Text] [Related]
27. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T
Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973
[TBL] [Abstract][Full Text] [Related]
28. Does the quality of endoscopic equipment influence the recurrence rate after photodynamic diagnosis-assisted transurethral resection of bladder tumor?
Nakagawa R; Nohara T; Kano H; Makino T; Naito R; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Mizokami A
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104023. PubMed ID: 38401816
[TBL] [Abstract][Full Text] [Related]
29. Poor Prognosis With Intravesical Bacillus Calmette-Guérin History After Photodynamic Diagnosis-assisted Transurethral Resection Using 5-Aminolevulinic Acid.
Makino T; Ofude M; Kawahara T; Hori T; Urata S; Miyagi T
In Vivo; 2022; 36(6):2952-2959. PubMed ID: 36309406
[TBL] [Abstract][Full Text] [Related]
30. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
31. Conventional white light imaging-assisted transurethral resection of bladder tumour (TURBT) versus IMAGE1S-assisted TURBT in non-muscle-invasive bladder cancer patients: trial protocol and 18 months results.
de la Rosette J; Martov A; Hurle R; Favre G; Mamoulakis C; Castanheira de Oliveira M; Stenzl A; Linares-Espinós E; Trelles Guzmán CR; Gravas S; Knoll T; Boz MY; Herrmann T; Laguna P
World J Urol; 2022 Mar; 40(3):727-738. PubMed ID: 34741631
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic Diagnosis-Assisted En Bloc Transurethral Resection of Bladder Tumor for Nonmuscle Invasive Bladder Cancer: Short-Term Oncologic and Functional Outcomes.
Miyake M; Nishimura N; Fujii T; Miyamoto T; Iida K; Hori S; Morizawa Y; Gotoh D; Nakai Y; Anai S; Torimoto K; Tanaka N; Fujimoto K
J Endourol; 2021 Mar; 35(3):319-327. PubMed ID: 32940054
[No Abstract] [Full Text] [Related]
33. Investigation on the Usefulness of Photodynamic Diagnosis-assisted Targeted Bladder Biopsy: Japanese Real-world Study.
Arai T; Sazuka T; Oka R; Tsukamoto R; Sato H; Goto Y; Imamura Y; Sakamoto S; Ichikawa T
Anticancer Res; 2023 Aug; 43(8):3615-3621. PubMed ID: 37500129
[TBL] [Abstract][Full Text] [Related]
34. [Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)].
Sugino Y; Nishikawa K; Kato M; Sasaki T; Kato M; Masui S; Yoshio Y; Kanda H; Sugimura Y; Inoue T
Hinyokika Kiyo; 2021 Jul; 67(7):303-308. PubMed ID: 34353010
[TBL] [Abstract][Full Text] [Related]
35. Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.
Fujita N; Hatakeyama S; Okita K; Momota M; Narita T; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
Urol Oncol; 2021 Mar; 39(3):191.e9-191.e16. PubMed ID: 32713622
[TBL] [Abstract][Full Text] [Related]
36. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin therapy.
Kikuchi H; Abe T; Miyake M; Miyata H; Matsumoto R; Osawa T; Nishimura N; Fujimoto K; Inokuchi J; Yoneyama T; Tomida R; Numakura K; Matsushita Y; Matsumoto K; Sato T; Taoka R; Kobayashi T; Kojima T; Matsui Y; Nishiyama N; Kitamura H; Nishiyama H; Shinohara N
Jpn J Clin Oncol; 2024 Feb; 54(2):192-200. PubMed ID: 37974430
[TBL] [Abstract][Full Text] [Related]
37. The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer.
Nishimura N; Miyake M; Miyamoto T; Tomizawa M; Shimizu T; Morizawa Y; Hori S; Gotoh D; Nakai Y; Torimoto K; Tanaka N; Fujimoto K
Jpn J Clin Oncol; 2023 Mar; 53(4):343-348. PubMed ID: 36585780
[TBL] [Abstract][Full Text] [Related]
38. [A systematic review and meta-analysis to assess the recurrence-free survival in non-muscle invasive bladder cancer after transurethral resection guided by 5-aminolevulinic acid-induced photodynamic diagnosis compared with white-light transurethral resect].
Rolevich AI; Evmenenko AA
Urologiia; 2016 Aug; (4):137-146. PubMed ID: 28247741
[TBL] [Abstract][Full Text] [Related]
39. Patients with Non-Muscle-Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guérin Intravesical Instillation Therapy.
Maeyama R; Ikeda M; Shimura S; Amano N; Murakami Y; Yamada Y; Koguchi D; Tachibana T; Kawamura M; Sakata Y; Hagiwara M; Matsumoto K; Iwamura M
Chemotherapy; 2023; 68(4):190-196. PubMed ID: 35390791
[TBL] [Abstract][Full Text] [Related]
40. Should intravesical Bacillus Calmette-Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
PLoS One; 2018; 13(11):e0208267. PubMed ID: 30496283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
